VYOME HOLDINGS, INC. Advertising Expense
VYOME HOLDINGS, INC. (HIND) reported Advertising Expense of $700.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AdvertisingExpense · last filed 2025-04-04
- VYOME HOLDINGS, INC. advertising expense for fiscal 2024 was $700.00K, a 68.18% decline from fiscal 2023.
- VYOME HOLDINGS, INC. advertising expense for fiscal 2023 was $2.20M, a 67.65% decline from fiscal 2022.
- VYOME HOLDINGS, INC. advertising expense for fiscal 2022 was $6.80M, a 126.67% increase from fiscal 2021.
- VYOME HOLDINGS, INC. advertising expense for fiscal 2021 was $3.00M, a 500.00% increase from fiscal 2020.
| Period end | Advertising Expense 12 month | Advertising Expense 12 month as first filed |
|---|---|---|
| 2024-12-31 | $700.00K 10-K · filed 2025-04-04 | |
| 2023-12-31 | $2.20M 10-K · filed 2025-04-04 | |
| 2022-12-31 | $6.80M 10-K · filed 2024-04-01 | |
| 2021-12-31 | $3.00M 10-K · filed 2023-04-17 | |
| 2020-12-31 | $500.00K 10-K · filed 2022-04-08 | $100.00K 10-K · filed 2021-03-12 |
| 2019-12-31 | $800.00K 10-K · filed 2021-03-12 | |
| 2018-12-31 | $3.80M 10-K · filed 2020-02-27 | |
| 2017-12-31 | $2.90M 10-K · filed 2019-02-22 | |
| 2016-12-31 | $900.00K 10-K · filed 2018-03-05 | |
| 2015-12-31 | $300.00K 10-K · filed 2018-03-05 | |
| 2014-12-31 | $300.00K 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |